Here, Paul Sullivan, Associate Director, Business Development, and Craig Baker, Executive Vice-President, both of Noble, provide data from recent patient studies to emphasise the importance of training devices in improving adherence to, and compliance with, inhaled therapeutics. Noble-respiratory-issue-62